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Kidney ischemia reperfusion (IR) contributes to the development of acute kidney injury. The hypoxic 
conditions in ischemic damage lead to oxidative stress and apoptotic cell death. We investigated the 
effects of vitamin D3 (Vit D) and erythropoietin (EPO) on microRNA‑21(miR‑21) expression in renal 
IR. Wistar rats were divided into five groups including the control, vehicle + IR, Vit D + IR, EPO + IR, 
and Vit D + EPO + IR groups. The animals were unilaterally nephrectomized and subjected to 45 min 
of renal pedicle occlusion followed by 24 h reperfusion. Vitamin D3 and EPO were administered prior 
to ischemia. After 24 h reperfusion, the kidney samples were collected for the detection of miR‑21, 
heat shock protein 70 (hsp70) and caspase‑3 expression levels. Kidney IR significantly increased the 
expression of miR‑21, hsp70 and capase‑3 and blood urea nitrogen (BUN)‑Cr levels. Treatment with 
vitamin D3 and EPO significantly decreased the BUN‑Cr levels and hsp70 and caspase‑3 expression. 
Also, the co‑administration of two drugs significantly increased miR‑21 expression. It seems that 
vitamin D3 or EPO administration could protect the kidney against IR injury. However, vitamin D3 and 
EPO co‑treatment was the most effective compared with the other treatment groups.
Kidney ischemia-reperfusion injury (IRI), the important cause of acute kidney injury (AKI), is a major compli-
cation after renal transplantation in clinical setting. Ischemia-reperfusion (IR) injury is a main contributor to 
leading cause of death worldwide. The hypoxic state arisen due to ischemic injury leaves tissues more sensitive 
to oxygen once perfusion is restored. However, reperfusion contributes to cellular damage and reactive oxygen 
species (ROS) production. Moreover, the initial hypoxic condition and reperfusion leads to activation of immune 
and inflammatory responses which can result in necrosis or apoptosis by damaging cellular DNA, proteins and 
cellular integrity. Therefore, it is essential to develop interventions to prevent ischemia-induced  AKI1,2.
Micro RNAs (miRNAs) are short, endogenous, single stranded noncoding RNAs which contain approximately 
22–25 nucleotides. They modulate gene expression by hybridization to messenger RNA (mRNA) leading to 
translational degradation of the target  mRNA3. As a hematopoietic miRNA, miR-21 can be induced by hypoxia 
conditions such as renal IR injury and upregulated in kidney diseases and it might be used as a diagnostic bio-
marker in renal diseases. Previous studies have identified the induction of miR-21 through cell intrinsic as well 
as extrinsic pathways is vital in preventing tubular epithelial cell (TEC) apoptosis and an essential role is assumed 
for TGF-β (tubular growth factor-β) in renal IRI. Furthermore, it has been suggested that the induction of miR-
21 expression in TEC occurs as the result of TGF-β signaling. Also, in the kidney, fibrosis is probably mediated 
by TGF-β signaling, as well as hypoxia or ischemia, through their effect on miR-21 expression. In TEC, TGF-β 
stimulation and IR lead to increased processing of pri-miR-21 by which TGF-β affects miR-21 expression. In renal 
undergoing IRI, pri-miR-21 is generally upregulated at early time-points, although miR-21 is usually upregulated 
at all time-points. The expression of miR-21 is gradually elevated following IR damage. All these findings imply 
an important role for miR-21 during renal IR  injury4.
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MiR-21, an anti-apoptotic miRNA which plays a role in several processes that occur as a result of IRI. Induc-
tion of hypoxia or ischemia in tubular epithelial cells results in upregulation of miR-21. As a result, the over-
expression of miR-21 leads to reduced cell apoptosis. Also, miR-21 is found to exhibit a protective role against 
hypoxia-induced cell apoptosis and inflammation in the IR injury by inhibiting the caspase 3-induced apopto-
sis. Therefore, miR-21 may play a major role in the responses to ischemic injury and attenuate cell damage via 
regulating the programmed cell death and Akt  pathway5. The pro-apoptotic protein (caspase-3) is an important 
apoptosis-related protein within the intrinsic apoptotic pathway. Caspase-3 is well known to act downstream of 
Bcl: Bax, and plays a major role in the execution of apoptosis. The activity of caspase-3 has been considered as 
an index of the process of  apoptosis6.
Heat shock proteins (HSPs) are abundant cellular proteins that play important roles in mediating protein 
assembly, folding or refolding stress, denatured proteins and initiating cell death. The expression of HSPs can 
be upregulated by various stressors in a process termed heat shock response. Their clinical application such as 
ischemic conditions in transplantation and major surgeries is due to the cytoprotective effects of hsps. Hsp70 
within the cells is located in the cytosol, mitochondria and nucleus. Hsp70 is induced by stressed cells to counter 
cellular damage and hasten recovery. Hsp70 induction ameliorates renal tubule-interstitial fibrosis and renal 
tubular epithelial cell apoptosis in IR injury. Furthermore, it prevents damage and restores normal cell func-
tion in the kidney following ischemia-reperfusion injury. In renal IR, hsp70 limits apoptosis by controlling the 
activity of the kinases Akt that regulate the activity of the pro-apoptotic protein Bax. Therefore, the hsp70 levels 
following renal IR inversely correlate with tubular injury, apoptosis and renal  dysfunction7,8.
As a circulating hormone in the body, Vitamin D is indispensable for mineral homeostasis and is normally 
transported in the circulation by the vitamin D binding protein. In the liver, it is hydroxylated on its side chain 
to form 25-hydroxyvitamin D. However, the kidney is the primary organ where the active form of vitamin D, 
1,25-dihydroxyvitamin D3 [1,25(OH)2 D3] or calcitriol is produced. The classical 1,25(OH)2 D3 pathway neces-
sitates the nuclear vitamin D receptor (VDR), which is a transcription factor for 1,25(OH)2 D3 target  genes9.
Vitamin D3 (1, 25(OH)2D3) is the biological active form of vitamin D which exhibits several physiological 
activities including the regulation of calcium homeostasis, immune functions, anti-fibrotic and antioxidant 
properties. Furthermore, it reduces cell death and necrosis induced by ROS, produces nephron-protective actions 
and a candidate intervention role against ischemic invasion might be considered for that. Meanwhile, the active 
form of vitamin D is produced in the kidney by mitochondria of the proximal tubules. Consequently, vitamin 
D levels are reduced after renal IR  injury10.
Erythropoietin (EPO) is a hypoxia-induced hematopoietic hormone, an important protein in production 
of erythrocytes. It mainly stimulates neovascularisation and angiogenesis, which improves blood flow and is 
predominantly expressed in the kidney in response to hypoxia. The physiological effects of erythropoietin are 
mediated by binding to erythropoietin receptors (EPORs), that are found in a variety of locations, including 
mesangial, glomerular and tubular epithelial  cells11. The important effects of EPO include reduction in free 
radicals and proinflammatory cytokines. The recombinant human EPO (rHuEPO) attenuates oxidative stress-
associated lipid peroxidation, the influx of inflammatory cell and apoptotic process. It is revealed that EPO can 
potentially preserve against IR-induced liver, heart and lung  injury12.
Since vitamin D3 as well as EPO have antioxidant and anti-apoptotic effects and hypoxia/re-oxygenation were 
shown to contribute to the apoptotic cell death following renal ischemia/reperfusion injury, thus the purpose 
of this study was to investigate the protective effect of vitamin D and EPO against renal IR damage using the 
evaluation of hsp70, caspase3 and miR-21 expression.
Material and methods
Animals and surgery. For the study, 30 Adult Wistar rats (weighing 200–250 g) were obtained from the 
experimental animal house. All the protocols and procedures of the study were approved by the Institutional 
Animal Ethics Committee (ethics code: IR.ARUMS.REC.1399.176). The rats were kept in controlled tempera-
ture (21 ± 2 °C) and humidity (60 ± 5%) environment with free access to water ad libitum and food and under 
12–12 h light–dark cycle.
For the induction of the anesthesia, 50 mg/kg ketamine and 10 mg/kg xylazine were given by intra-peritoneal 
injection. The animal was placed at right flank position, after minimal dissection under the last rib, right nephrec-
tomy was performed and the incision was sutured. Then, the rat was placed at left flank position, after minimal 
dissection under the last rib, left renal pedicle (artery and vein) was exposed. It was occluded by an atraumatic 
microvascular clamp for 45 min to induce ischemia and then subjected to reperfusion for 24 h. All animals had 
right nephrectomy and the presence of ischemia was visually confirmed by observing blanching of the kidney.
The rats were randomly divided into five groups of six rats in each group. The control group (N = 6) underwent 
only nephrectomy without occlusion. The other groups were as follows:
Vehicle + IR group.
Vit D (Vitamin D3) + IR group.
EPO + IR group.
Vit D + EPO + IR group.
Erythropoietin (Neorecormom, Roche, Mannheim, Germany) was administered as a 1000 U/kg single dose 
IP, 30 min before  ischemia13. Vitamin D3 used in the present study was obtained from Sigma-Aldrich (USA) 
and was dissolved in ethanol, diluted with saline and adjusted to a final concentration of 10 mg/kg14. Vitamin 
D3 was injected intraperitoneally, prior to ischemia, an equal amount of saline supplemented with the required 
volume of ethanol was used as the vehicle.
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Biochemical assays. Blood samples were taken by cardiac puncture, and left kidney tissues were collected 
after twenty four hours of reperfusion in each group. One part of kidney was snap-frozen in liquid nitrogen for 
protein and RNA isolation followed by transference to a − 80 °C freezer, and the other part of left kidney was 
fixed for histological analysis. The blood samples were centrifuged at approximately 2000 rmp for 20 min. The 
serum blood urea nitrogen (BUN) and creatinine (Cr) levels to assess the renal function were measured, using 
the Auto-analyser (Alycon 300 USA) with original kits.
Quantitative real‑time polymerase chain reaction (qRT‑PCR). Total RNA was isolated from cells. 
Quantitative RT-PCR was performed with an ABI 7500 Fast Real Time PCR system (Applied Bio-systems, USA) 
using a reverse transcriptase kit (Takara) and SYBR Green Master Mix kit (Takara) according to the manufac-
turer’s instructions. Reverse transcription reaction conditions were processed at 42 °C for 15 min, followed by 
3 min at 95 °C. The thermal cycling conditions were processed at 95 °C pre-denaturation, followed by 40 cycles 
(95 °C for 15 s; 60 °C for 30 s; 72 °C for 60 s). Relative quantification was determined by normalization to U6. The 
primers are shown in Table 1. All the qRT-PCR expression experiments were performed in triplicates to ensure 
the reproducibility. The relative gene expression was calculated using  2−∆∆Ct  method15.
Western blot analysis. Proteins were extracted from kidney, and the protein concentrations were meas-
ured using a BCA assay kit (TaKaRa BIO INC, Japan). The protein samples were resolved in a 10–12% sodium 
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. Proteins were then transferred to polyvinylidene fluo-
ride (PVDF) membrane, and blocked with 5% nonfat milk in Tris-buffered saline-Tween (TBST) 20 for 2 h at 
room temperature. Membranes were then incubated with primary antibody overnight. The antibodies were 
shown as follows: anti-Caspase-3 (1:1000; Santa Cruz Biotechnology), or anti-HSP70 (1:1000; Santa Cruz Bio-
technology). An anti-β-actin antibody was used as control. Membranes were washed and incubated for 2 h in 
the presence of appropriate horseradish peroxidase (HRP)-conjugated secondary antibody. The positive reaction 
was visualized by using 3, 3′-diaminobenzitine (DAB) solution (Sigma, St. Louis, MO) with a chemiluminescent 
Immobilon Western blotting detection  system16,17.
Histopathological analysis. The renal samples of the experimental animals were sectioned and fixed in 
10% buffered-formalin solution and then the sections were embedded in paraffin. Sections of 5 µm were taken, 
stained with periodic acid Schiff (PAS), and then examined under light microscope in a blinded manner by a 
pathologist. Histological changes were scored on a 4-point scale: (−) none, (+) mild, (++) moderate, and (+++) 
severe  damage18.
Statistical analysis. All the data were reported as mean ± standard deviation (SD). Significance testing 
between groups was performed using one-way analysis of variance (ANOVA) followed by multiple comparison 
procedures using post hoc complementary test, with SPSS version 19.0 and Graph Pad Prism version 8.4.3 (686). 
A statistical significance was defined at P < 0.05.
Results
The effect of vitamin D3 and erythropoietin on renal IR injury was investigated in 45 min of renal ischemia 
followed by 24 h reperfusion. The miR-21 expression is outlined in Fig. 3 and the expression levels of HSP70 
and caspase 3 are represented in Figs. 4, 5 and 6. Figure 6 indicates western blot bands for HSP 70 and cleaved 
caspase-3 protein expression in studying groups and the results of histological evaluation are shown in Table 2.
Effects of ischemia reperfusion. The BUN-Cr levels in the IR group in comparison to those from con-
trol group were significantly higher (P < 0.0001, Figs.  1, 2). An increased expression of MiR-21 in the renal 
tissues was detected after ischemia-reperfusion. The microarray data were confirmed by qRT-PCR to measure 
the expression of this miRNA in the samples of the experimental kidney. MiR-21 showed upregulation after 
ischemia-reperfusion as shown in Fig. 3. The expression of HSP 70 and caspase-3 in IR group was significantly 
higher as compared with the control group (P < 0.01, Figs.  4, 5). The expression of HSP70 is one of the key 
mechanisms which works against cellular injury; by inhibiting subsequent caspase activation and decreasing 
mitochondrial injury, it plays an important role in protecting renal epithelial cells from apoptosis (Fig. 6).
Histological assessment of the kidneys showed that there were no morphological changes in the control group 
(Fig. 7A). In the IR group, thickening of basement membrane, acute tubular necrosis (ATN), glomerular atrophy 
and lymphocyte infiltration were very obvious (Fig. 7B).
Table 1.  Sequence of primers used for RT-PCR.
RNA name Sequence
miR-21 stem GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACT CAACA 
miR-21 forward CCG CAG GTA GCT TAT CAG A
U6 stem GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG ACA AAA ATAT 
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Effects of vitamin D3 on renal ischemia reperfusion. Serum BUN-Cr levels in the vitamin D3 + IR 
group were lower than those of the IR group (Figs. 1, 2). The vitamin D-treated rats did not show any changes of 
miR-21 expression in comparison to the IR group, but this expression was considerably enhanced in compari-
son to the control group (Fig. 3). HSP 70 and caspase-3 expressions were significantly reduced in the vitamin D 
Table 2.  Tubular and Glomerular changes in the kidney after 24 h reperfusion (PAS). A minimum of 10 fields 
for each kidney slide were examined and assigned for severity of changes using Scores on a scale of: (–) none, 
(+) mild, (++) moderate, and (+++) severe damage. (n = 6 for each group).
Groups Glomerular atrophy Acute tubular necrosis Lymphocyte infiltration
Thickening of basement 
membrane Hyaline cast
Control − − − − −
IR +++ +++ +++ +++ +++
Vit D − + ++ − +
EPO − + + − ++
Vit D + EPO − − + − −
Figure 1.  Blood urea nitrogen (BUN) levels. ****P < 0.0001 versus control group. ####P < 0.0001, ****P < 0.0001 
versus IR group. ***P < 0.001 versus Vit D. IR Ischemia-reperfusion, Vit D vitamin D, EPO erythropoietin.
Figure 2.  Creatinine (Cr) levels. ****P < 0.0001 versus control group. **P < 0.01, ***P < 0.001, 
####P < 0.0001versus IR group. ##P < 0.01 versus Vit D.
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Figure 3.  Vitamin D and erythropoietin affect ischemia-reperfusion by regulating miR-21. Relative expression 
of miR-21 in renal cell was detected by qRT-PCR. Data represent the mean ± SD. *P < 0.05, ***P < 0.001 versus 
control group. #P < 0.05 versus IR group. ~P < 0.05 versus Vit D.
Figure 4.  Effect of vitamin D and erythropoietin on ischemia/reperfusion-induced alterations in HSP 70 
protein expression in renal tissue. Protein expression level of HSP70 was detected by western blot analysis. 
**P < 0.01 versus control group. ***P < 0.001 versus IR group. ##P < 0.01 versus EPO group. HSP70; heat shock 
70 kDa protein.
Figure 5.  Effect of vitamin D and erythropoietin on the caspase-3 expression after renal IR injury. Cleaved 
caspase 3 was detected using Western blot. **P < 0.01 versus control group. *P < 0.05 versus IR group.
6
Vol:.(1234567890)
Scientific Reports |        (2020) 10:20906  | https://doi.org/10.1038/s41598-020-78045-3
www.nature.com/scientificreports/
group when compared with IR group (P < 0.001, Figs. 4, 5). The administration of vitamin D resulted in note-
worthy decline in histopathological changes induced by ischemia reperfusion (Fig. 7C).
Effects of erythropoietin on renal ischemia reperfusion. Serum BUN-Cr levels in the EPO + IR 
group were significantly lower than those of the IR group (P < 0.0001, Figs. 1, 2). It was found that in erythropoi-
Figure 6.  Representative western blot bands for HSP 70 and cleaved caspase-3 protein expression in each 
group. IR Ischemia-reperfusion, Vit D vitamin D, EPO erythropoietin, HSP70 heat shock 70 kDa protein.
Figure 7.  Histopathological evaluation of rat kidneys after ischemia-reperfusion. Kidney sections are stained 
by periodic acid Schiff (PAS). (A) The normal renal tissue structure in the control group. Healthy appearance of 
glomerular and tubular cells (40 × PAS). (B) Thickening of basement membrane (tbm), acute tubular necrosis 
(ATN), glomerular atrophy (ga), and lymphocyte infiltration (lyi) in IR group. (C) The Lymphocyte infiltration 
(lyi) in the Vit D group. (D) The degree of hyaline cast (hc) in the EPO group. (E) The normal basement 
membrane in the Vit D + EPO group (40 × PAS).
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etin-treated animals, the miR-21 expression was elevated in comparison to the IR group, as erythropoietin sig-
nificantly upregulated miR-21 when compared with the control (P < 0.05, Fig. 3). In the EPO group, the expres-
sion of HSP 70 and caspase-3 were decreased in comparison to IR group (Figs. 4, 5). Also, in the group treated 
with EPO, there were moderate microstructural alterations in the renal tissues (Fig. 7D).
Effects of vitamin D3 and erythropoietin on renal ischemia reperfusion. In the vit D + EPO + IR 
group, the serum level of BUN-Cr was significantly lower than that in the IR group (P < 0.0001, Figs.  1, 2). 
The study showed that in the group treated with vitamin D and EPO, the miR-21 expression was significantly 
increased in comparison to the IR group and vitamin D (P < 0.05, Fig. 3). As shown in Figs. 4 and 5, vitamin D 
and EPO significantly downregulated HSP 70 and caspase-3 expression in comparison to IR group (P < 0.05). 
Also, vitamin D and EPO co-treatment severely attenuated the histological changes, nearly the normal micro-
structure of kidney was preserved by vitamin D and EPO pretreatment. Thus, combination therapy appears to 
have considerable improvement on ischemia–reperfusion injury (Fig. 7E).
Discussion
Acute kidney injury induced by ischemia-reperfusion injury is a major cause of mortality among patients during 
partial nephrectomy, especially renal transplantation. Ischemia-reperfusion injury has been reported to result 
in the development of oxidative stress via the production of free radicals, initiate a series of cellular events that 
lead to necrotic and apoptotic cell death and increase generation of inflammatory cytokines. Therefore, the 
investigation and development of effective treatment to reduce renal damage from IR injury is  necessary19,20.
In this study, renal IR injury resulted in both tubular and glomerular dysfunction. IR significantly enhanced 
the levels of BUN-Cr, suggesting an impaired glomerular filtration rate which was reduced by vitamin D3 and 
erythropoietin administration. It is reported that the pretreatment with EPO or vitamin D3 prior to ischemia 
decreases the renal dysfunction-induced by IR damage and regulates glomerular filtration  rate21,22. Also, the 
serum levels of BUN-Cr decreased by the co-administration of two agents (Vit D + EPO), which shows that the 
co-treatment improves the recovery of renal function.
We found that renal IR elevated the miR-21 expression. Increased expression levels indicate a cellular defen-
sive response to activate apoptotic pathways after renal IR. MiR-21 is an important anti-apoptotic and hemat-
opoietic  miRNA23. Several studies have suggested that miR-21 expression may be elevated in cells tolerant to 
hypoxia and may be protective against ischemia-induced hypoxia, so hypoxic conditions are expected to induce 
the expression of miR-21 in renal epithelial  cells24,25. The overexpression of miR-21 in renal IR may contribute 
to the protection of renal epithelial cells against IR injury by attenuating apoptosis of renal tubular  cells26. Eryth-
ropoietin enhanced the expression of miR-21; it was mentioned above that EPO is hematopoietic hormone and 
miR-21 is a hematopoietic miRNA. Probably this hormone causes the hematopoietic effects through upregu-
lation of miR-21 expression. Also, the co-administration of vitamin D and EPO (Vit D + EPO) significantly 
increased the miR-21 expression. This finding may indicate that vitamin D and EPO co-treatment decreases the 
renal IR-induced apoptosis and protects against IR injury by upregulation of miR-21 expression. Furthermore 
in compatibility with our findings, it was reported that erythropoietin significantly attenuates myocardial IR-
induced apoptosis and autophagy activation via up-regulating miR-21 and the protective effect of EPO against 
myocardial IR injury is associated with regulating miR-2115.
Our results demonstrated that IR significantly increased the expression of HSP 70 and caspase-3. Heat shock 
proteins protect against apoptosis and cell injury. Their expression is upregulated upon exposure to stressful 
conditions such as hypoxia, oxidative stress and ischemia. It has been indicated that HSP70 protects cells against 
ischemic injury and accumulates at higher levels after oxidative stress to maintain cell  homeostasis8,27. In spite 
of the fact that previous researches have revealed that EPO induced an expression of HSP 70 and resulted in a 
significant increase in myocardial HSP70 content in the myocardial infarct induced by IR  injury28, the results 
of the present study showed that erythropoietin insignificantly decreased the expression of HSP70. Also, the 
administration of vitamin D especially co-treatment with vitamin D and EPO significantly reduced the hsp70 
expression. These findings may show that vitamin D and erythropoietin decreased the magnitude of oxidative 
stress and ischemic injury, as a result the expression level of hsp70 has been reduced.
Furthermore, we demonstrated that the expression level of caspase-3 was significantly decreased by two agents 
(VitD + EPO). Caspase-3 is an important apoptosis-related protein within the intrinsic apoptotic pathway. The 
activity of caspase-3 has been considered as an index of the process of  apoptosis29,30. Apoptosis is an important 
cause of renal damage induced by ischemia-reperfusion and IR initiates a series of cellular events that lead to 
apoptotic cell death. It was revealed that caspase-3 expression is promoted after IR injury, consistent with this 
finding, we showed that the caspase-3 expression was significantly elevated after IR injury. However, this overex-
pression of caspase-3 was significantly reduced by the co-administration of vitamin D and EPO. This effect may 
be due to the following reasons. First, vitamin D and EPO are potent anti-apoptotic agents, which downregulate 
pro-apoptotic protein (caspase-3)  expression31. Second, the overexpression of miR-21 by vitamin D and EPO 
co-treatment could inhibit apoptosis and decrease the expression of caspase-332.
Our histological evaluation showed that ischemia reperfusion caused glomerular and tubular changes as 
shown by acute tubular necrosis, thickening of basement membrane and lymphocyte infiltration. We found 
that vitamin D had protective effects on tubular function. Sezgin et al.21 reported that vitamin D has protective 
effects on IR-induced renal injury and the morphological changes are reversed by vitamin D treatment. Eryth-
ropoietin treatment decreased the pathological changes associated with renal IR injury. The cyto-protective 
effects of vitamin D and EPO may be due to their powerful antioxidant and anti-apoptotic  properties31,33. Also, 
vitamin D and EPO co-treatment reduced the morphological alterations in renal tissue caused by IR injury, nearly 
the normal renal structure was preserved by vitamin D + EPO. Therefore, the combination therapy appears to 
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have synergistic protective effects, and to be the most effective compared with the other treatment groups. In a 
nutshell, Fig. 8 illustrates how the molecular components involved in vitamin D and erythropoietin-mediated 
renoprotection relate to each other.
Conclusion. In conclusion, apoptotic cell death and hypoxia are considered to be principal components 
involved in the pathophysiological tissue changes observed during renal ischemia reperfusion. The administra-
tion of vitamin D3 and EPO, which are known antioxidant and anti-apoptotic agents, appears to have protec-
tive effects on IR-induced renal injury as indicated by lower expression of caspase-3 and higher expression of 
miR-21. Also, the co-treatment with vitamin D3 and EPO decreased morphological damage and renal dysfunc-
tion. However, the co-administration of vitamin D3 and EPO exerted more nephroprotective effects than single 
application of them. Therefore, combined therapy may be an alternative option for the decrease of IR-induced 
renal injury.
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